Ophthalmology · Kissimmee, FL
NPI
1255599866
Since 2008
Specialty
Ophthalmology
Code 207W00000X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
2225 N Central Ave
Kissimmee, FL, 34741
Phone (407) 933-2908
Groups this clinician bills Medicare through
Medicare paid, 2024
$439K
7,755 services
Medicare patients, 2024
425
Average age 77
Drug cost, 2024
$1.9M
2,711 prescriptions
Company payments, 2025
$445
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Haijiang Lin was code 92134 (computerized ophthalmic imaging), 840 times for 366 patients. In total Haijiang Lin billed 7,755 services in 29 codes, and Medicare paid $439K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-12-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92134 Computerized Ophthalmic Imaging | Office | 840 | 366 | $29.36 | $25K |
| 67028 Intravitreal Injection | Office | 470 | 100 | $90.83 | $43K |
| J0178 Injection, aflibercept, 1 mg | Office | 430 | 50 | $657.46 | $283K |
| 92014 Ophthalmological E&M | Office | 323 | 277 | $88.17 | $28K |
| J3490 Unclassified drugs | Office | 279 | 72 | $61.74 | $17K |
| 92012 Ophthalmological E&M | Office | 250 | 152 | $66.26 | $17K |
| 92004 Ophthalmological E&M | Office | 60 | 60 | $94.14 | $5,649 |
| 99212 Office E&M - Established | Office | 57 | 49 | $31.45 | $1,793 |
| 92250 Angiography | Office | 37 | 34 | $23.91 | $885 |
| 92083 Vision, Hearing, and Speech Services | Office | 30 | 24 | $48.83 | $1,465 |
| 92133 Computerized Ophthalmic Imaging | Office | 30 | 26 | $24.43 | $733 |
| 76514 Ultrasound - Nonspecific | Office | 14 | 14 | $7.35 | $103 |
By year: 2022 $145K for 2,811 services; 2023 $221K for 3,358 services; 2024 $439K for 7,755 services.
Medicare prescription drug claims, 2024
In 2024, the drug Haijiang Lin prescribed most often to Medicare patients was Eylea (Aflibercept), with 619 prescriptions and refills. In total Haijiang Lin wrote 2,711 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eylea Aflibercept | 619 | 621 | 174 | $1.6M |
| Latanoprost Generic | 529 | 1,194 | 190 | $5,313 |
| Dorzolamide Hcl Generic | 282 | 525 | 120 | $4,428 |
| Prednisolone Acetate Generic | 271 | 356 | 165 | $11K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 253 | 467 | 112 | $3,389 |
| Ketorolac Tromethamine Generic | 187 | 268 | 89 | $6,881 |
| Brimonidine Tartrate Generic | 149 | 314 | 59 | $6,112 |
| Timolol Maleate Generic | 113 | 247 | 45 | $1,374 |
| Eylea Hd Aflibercept | 34 | 34 | 15 | $105K |
| Rhopressa Netarsudil Mesylate | 32 | 48 | 18 | $14K |
| Lumigan Bimatoprost | 31 | 59 | 17 | $14K |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 28 | 29 | 25 | $1,434 |
| Alphagan P Brimonidine Tartrate | 18 | 43 | 11 | $9,688 |
| Travoprost Generic | 17 | 26 | Under 11 | $2,107 |
| Moxifloxacin Moxifloxacin Hcl | 14 | 14 | 12 | $478 |
Brand drugs: 1,309 claims; generic drugs: 1,402 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Haijiang Lin $445 ($445 in general payments such as food, travel and fees) from 9 companies. The largest payer was Regeneron Healthcare Solutions, Inc. with $107.
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. REGN | 4 | $107 |
| Astellas Pharma US Inc 4503.T | 3 | $73.3 |
| Apellis Pharmaceuticals, Inc. APLS | 3 | $61.85 |
| Mallinckrodt Hospital Products Inc. | 2 | $53.89 |
| Abbvie Inc. ABBV | 3 | $50.83 |
| Harrow Eye, LLC | 2 | $45.98 |
| Genentech USA, Inc. ROG.SW | 1 | $24.65 |
| Oyster Point Pharma, Inc. | 1 | $14.03 |
| Alcon Vision LLC ALC | 1 | $13.86 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.